Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             134 results found
no title author magazine year volume issue page(s) type
1 (A6) Aplastic anaemia (AA) or hypoplastic MDS? Geary, C.G.
 1991
 15 S p. 1-
1 p.
 article
2 Abnormal multimeric pattern of platelet von willebrand factor (Plt vWF) in myelodysplastic syndromes (MDS) 1991
 15 S p. 30-
1 p.
 article
3 Acanthocytosis (spur cells) in disparate clinical states — myelodysplasia and alzheimer's disease Goodall, H.B.
 1991
 15 S p. 19-
1 p.
 article
4 A case of pre-myelodysplasia 1991
 15 S p. 23-
1 p.
 article
5 (A4) Chronic myelomonocytic leukemia (CMML) Pierre, Robert V.
 1991
 15 S p. 1-
1 p.
 article
6 (A5) Chronic neutrophilic leukemia with dysplastic features (CNL-D). A report of seven patients Symeonidis, A.
 1991
 15 S p. 1-
1 p.
 article
7 (A1) Definition and classification of the myelodysplastic syndromes (MDS) 1991
 15 S p. 1-
1 p.
 article
8 (A9) Dysplastic changes of peripheral blood polymorphs in elderly de novo AML patients — sign of a link to MDS? Hast, R
 1991
 15 S p. 2-
1 p.
 article
9 (A8) Heterogeneity of acquired idiopathic sideroblastic anaemia (AISA) Garand, R.
 1991
 15 S p. 2-
1 p.
 article
10 A method for the prediction of the clinical course of MDS Ryausova, L.Y.
 1991
 15 S p. 16-
1 p.
 article
11 (A7) Myelodysplastic syndromes with bone marrow fibrosis: A myelodysplastic disorder with proliferative features 1991
 15 S p. 2-
1 p.
 article
12 Analysis of 36 cases of secondary myelodysplastic syndrome 1991
 15 S p. 20-
1 p.
 article
13 Assessment of cell proliferation in primary myelodysplastic syndromes 1991
 15 S p. 29-
1 p.
 article
14 Assessment of clonality in females heterozygous at the DXS255 locus 1991
 15 S p. 25-
1 p.
 article
15 Author index 1991
 15 S p. I-IV
nvt p.
 article
16 (B8) Case control study of occupational and environmental exposure and myelodysplasia West, Robert
 1991
 15 S p. 4-
1 p.
 article
17 (B9) Childhood MDS in Turkey — clinical experience in 25 cases Tuncer, A.M.
 1991
 15 S p. 5-
1 p.
 article
18 (B1) Epidemiology of myelodysplastic syndrome 1991
 15 S p. 3-
1 p.
 article
19 (B7) Establishing the incidence of MDS-population surveys Williamson, P.J.
 1991
 15 S p. 4-
1 p.
 article
20 (B6) MDS during medical surveillance of a refinary population Cowles, S.R.
 1991
 15 S p. 4-
1 p.
 article
21 (B4) Myelodysplastic syndromes and leukemias in atomic bomb survivors Tomonaga, Masao
 1991
 15 S p. 3-
1 p.
 article
22 Bone marrow transplantation (BMT) for myelodysplasia (MDS): alternative preparation with busulfan/cyclophosphamide (BU/CY) O'Donnell, M.R.
 1991
 15 S p. 31-
1 p.
 article
23 (B3) Organic solvents in leukaemogenesis Brandt, L.
 1991
 15 S p. 3-
1 p.
 article
24 (B5) Results from a semi-national registry of MDS cases in England and Wales Alexander, F.E.
 1991
 15 S p. 4-
1 p.
 article
25 (B2) Treatment induced myelodysplasia (t-MDS) 1991
 15 S p. 3-
1 p.
 article
26 (C7) Alterations in the p53 gene in primary myelodysplastic syndrome (pMDS) 1991
 15 S p. 6-
1 p.
 article
27 (C3) Chromosomal deletions in haematological malignancies Hirst, W.J.R.
 1991
 15 S p. 6-
1 p.
 article
28 (C11) Clonality of hematopoiesis in patients with aplastic anemia and myelodysplastic syndromes van Kamp, H.
 1991
 15 S p. 7-
1 p.
 article
29 (C1) Cytogenetics of MDS Mecucci, Cristina
 1991
 15 S p. 5-
1 p.
 article
30 (C9) Direct sequencing of C-FMS in myelodysplastic syndrome and AML 1991
 15 S p. 7-
1 p.
 article
31 Changes of purine metabolism in RBCS from patients with myelodysplastic syndromes 1991
 15 S p. 30-
1 p.
 article
32 Chromosome analyses of colonies in myelodysplastic syndrome Högh-Kristiansen, Inge
 1991
 15 S p. 23-
1 p.
 article
33 (C2) Implications of chromosome 5 involvment Le Beau, Michelle M.
 1991
 15 S p. 5-
1 p.
 article
34 Classification of the myelodysplastic syndromes (MDS): Criteria for their histologic recognition Frisch, Bertha
 1991
 15 S p. 15-
1 p.
 article
35 Clonal chromosome abnormalities identify myelodysplastic syndrome (MDS) complicating hairy cell leukemia (HCL) 1991
 15 S p. 23-
1 p.
 article
36 Clonal development (MDS) in aplastic anemia (AA) patients with long-term survival Castro-Malaspina, H
 1991
 15 S p. 25-
1 p.
 article
37 (C8) Microdeletion of CSFIR in myelodysplasia Boultwood, J
 1991
 15 S p. 7-
1 p.
 article
38 (C4) Molecular pathology of MDS Padua, R.A.
 1991
 15 S p. 6-
1 p.
 article
39 (C6) Mutations of the P53 gene in myelodysplastic syndromes (MDS). A report on 152 cases Fenaux, P.
 1991
 15 S p. 6-
1 p.
 article
40 Comparative studies of SCE in peripheral lymphocytes from patients with myelodysp lastic syndromes and aplastic anemia Xi-Jian, Wang
 1991
 15 S p. 24-
1 p.
 article
41 (C10) Studies of clonality in patients with refractory anaemia and chromosome deletions Abrahamson, G
 1991
 15 S p. 7-
1 p.
 article
42 Cyclic haemopoiesis in association with familial refractory anaemia Bowen, D.T.
 1991
 15 S p. 29-
1 p.
 article
43 Cytogenetical findings in refractory anemia with ring sideroblasts (RARS) Shtalrid, M.
 1991
 15 S p. 22-
1 p.
 article
44 Cytogenetic observations in myelodysplastic syndromes (MDS) before and after GM-CSF Jacobson, R.J.
 1991
 15 S p. 23-
1 p.
 article
45 Cytogenetic study of MDS evolving to AML Musilova, J.
 1991
 15 S p. 21-
1 p.
 article
46 Data on 700 MDS patients in Czechoslovakia 1991
 15 S p. 16-
1 p.
 article
47 (D11) Cytokine regulation of megakaryopoiesis in patients with myelodysplastic syndrome (MDS) 1991
 15 S p. 10-
1 p.
 article
48 (D9) Differentiation of blast cells in MDS and acute myeloid leukemia by automated image analysis 1991
 15 S p. 9-
1 p.
 article
49 (D2) Differentiation therapy in myelodysplastic syndrome 1991
 15 S p. 8-
1 p.
 article
50 Defective autologous and allogeneic mixed lymphocyte reaction (MLR) in patients with primary myelodysplastic syndromes (MDS) Symeonidis, A.
 1991
 15 S p. 29-
1 p.
 article
51 Deletions and gene polymorphisms of 5q located genes in 12 pat with myeloid leukemias 1991
 15 S p. 24-
1 p.
 article
52 Desferrioxamine treatment reduces blood transfusion requirements in patients with myelodysplastic syndrome Jensen, P-D.
 1991
 15 S p. 33-
1 p.
 article
53 Determination of clonality in myelodysplasia by polymerase chain reaction van Kamp, H.
 1991
 15 S p. 25-
1 p.
 article
54 (D4) Expression of the multidrug resistance ( MDR 1) gene in MDS 1991
 15 S p. 8-
1 p.
 article
55 (D3) Growth factor receptors 1991
 15 S p. 8-
1 p.
 article
56 (D5) Haemopoiesis in long-term marrow culture as an indicator of early myelodysplasia McMullin, M.F.
 1991
 15 S p. 8-
1 p.
 article
57 Diagnosis of clonality of myelodysplastic syndromes (MDS) by polymerase chain reaction (PCR) of phosphoglycerate kinase (PGK) gene 1991
 15 S p. 24-
1 p.
 article
58 Differential diagnosis of myelodysplasia (MDS) and erythroleukemia (FAB:M6). A multicenter I.G.C.I. trial 1991
 15 S p. 19-
1 p.
 article
59 (D6) IL-3 plus IL-6 improve hematopoiesis in long-term bone marrow cultures (LTBMC) of patients with myelodysplastic syndromes (MDS) Kourakli, A.
 1991
 15 S p. 9-
1 p.
 article
60 (D7) Increased circulating CD34+ cells in myelodysplastic syndromes: An adverse prognostic feature Marsden, K.A.
 1991
 15 S p. 9-
1 p.
 article
61 Disturbances of haemopoietic organisation and maturation in myelodysplastic syndromes demonstrated by differential staining with immunohistochemical markers Wilkins, B.S.
 1991
 15 S p. 15-
1 p.
 article
62 (D10) MDS marrow macrophages inhibit granulocyte-macrophage progenitors from normal marrow Yoshida, Y.
 1991
 15 S p. 10-
1 p.
 article
63 (D8) Multiparameter flow cytometry in patients with myelodysplastic syndromes Jensen, Inger Marie
 1991
 15 S p. 9-
1 p.
 article
64 (E9) BMT for MDS 1991
 15 S p. 12-
1 p.
 article
65 (E8) Effectiveness of attenuated chemotherapy in the treatment of myelodysplasia 1991
 15 S p. 11-
1 p.
 article
66 (E3) Has survival improved in the past ten years? Reynolds, Paul
 1991
 15 S p. 11-
1 p.
 article
67 (E7) Intensive chemotherapy in MDS 1991
 15 S p. 11-
1 p.
 article
68 (E6) Involvement of RAR-α in the RA inducible regulation of myeloid cell differentiation Hardas, B.D.
 1991
 15 S p. 11-
1 p.
 article
69 Electron microscopic observations on bone marrow: A study of 50 myelodysplastic syndromes (MDS) Irriguible, D.
 1991
 15 S p. 20-
1 p.
 article
70 (E2) Long-term survivors of the myelodysplastic syndromes Oguma, S.
 1991
 15 S p. 10-
1 p.
 article
71 (E11) Myelodisplastic syndrome (MDS) and secondary leukaemia (SEC-AL) treated by allogeneic BMT: a retrospective analysis from GITMO 1991
 15 S p. 12-
1 p.
 article
72 (E1) Natural history of myelodysplastic syndromes Sanz, Guillermo F
 1991
 15 S p. 10-
1 p.
 article
73 Factors other than Hb concentration influencing serum EPO levels in patients with MDSs 1991
 15 S p. 30-
1 p.
 article
74 Familial MDS Douglas, A.
 1991
 15 S p. 22-
1 p.
 article
75 (F5) A phase I–II trial of erythropoietin [epoetin-β] (EPO) in patients with myelodysplastic syndromes (MDS) Stone, R.
 1991
 15 S p. 13-
1 p.
 article
76 (F9) A phase I trial of recombinant human interleukin-3 (rhIL-3) in patients with myelodysplastic syndrome (MDS) and aplastic anemia (AA) 1991
 15 S p. 14-
1 p.
 article
77 (F3) Efficacy and safety of recombinant human erythropoietin (r-HuEPO) in anemic patients with myelodysplastic syndromes 1991
 15 S p. 13-
1 p.
 article
78 (F1) GM-CSF and IL-3 in the treatment of MDS Ganser, A.
 1991
 15 S p. 12-
1 p.
 article
79 (F8) GM-CSF treatment in myelodysplastic syndromes: Results of a multicenter randomized controlled study 1991
 15 S p. 14-
1 p.
 article
80 (F2) Granulocyte colony-stimulating factor (G-CSF) in the treatment of myelodysplastic syndromes (MDS) Greenberg, P.
 1991
 15 S p. 12-
1 p.
 article
81 (F7) Randomized phase II study with GM-CSF and low-dose ARAC in patients with “high risk” myelodysplastic syndromes 1991
 15 S p. 14-
1 p.
 article
82 (F4) Treatment of high risk myelodysplastic syndromes with sequential intermediate dose cytosine arabinoside and mitoxantrone (S-HAM) with or without GM-CSF: A prospective double blinded randomised study Hiddemann, W
 1991
 15 S p. 13-
1 p.
 article
83 (F6) Treatment of myelodysplastic syndromes with erythropoietin and granulocyte-CSF in combination 1991
 15 S p. 13-
1 p.
 article
84 Functional relevance of differentiation of AML blasts with GM-CSF and 1,25-dihydroxy-vitamin D3 (D3) Kelsey, S.M.
 1991
 15 S p. 31-
1 p.
 article
85 G-CSF and GM-CSF expression and paracrine/autocrine growth mechanisms in P-MDS 1991
 15 S p. 28-
1 p.
 article
86 (G1) The past, the present and the future Hamblin, Terry
 1991
 15 S p. 14-
1 p.
 article
87 Haematological, radiological and biological studies in myelodisplastic syndromes (MDS) 1991
 15 S p. 15-
1 p.
 article
88 Haematologic and biochemical parameters are strong prognostic indicators in chronic myelomonocytic leukaemia (CMML): A multivariate analysis of prognostic factors in 93 cases 1991
 15 S p. 17-
1 p.
 article
89 Iliac bone marrow findings and prognosis in MDS patients 1991
 15 S p. 15-
1 p.
 article
90 IL-2R: A prognostic factor for MDS patients 1991
 15 S p. 26-
1 p.
 article
91 IL-6 serum concentrations in patients with MDS Herold, M.
 1991
 15 S p. 27-
1 p.
 article
92 Immunophenotypic and clinical characteristics of acute leukemia following a myelodysplastic syndrome 1991
 15 S p. 26-
1 p.
 article
93 Influence of IL-8 on granulo-monocytic progenitor cell (CFU-GM) growth in normal persons and MDS patients 1991
 15 S p. 28-
1 p.
 article
94 In vitro patterns and morphology of myelodysplastic bone marrow in relation to patient prognosis 1991
 15 S p. 27-
1 p.
 article
95 In vivo induction of soluble IL-2R expression in MDS patients under treatment with IL-3 1991
 15 S p. 27-
1 p.
 article
96 Isolated thrombocytopenia as the sole initial manifestation of myelodysplasia Beris, Ph.
 1991
 15 S p. 19-
1 p.
 article
97 6-Merkaptopurin in the treatment of CMML 1991
 15 S p. 32-
1 p.
 article
98 Molecular genetic evidence for clonal proliferation in MDS Morita, K.
 1991
 15 S p. 24-
1 p.
 article
99 Monitoring of bone marrow CFU-GM in myelodysplastic syndromes 1991
 15 S p. 27-
1 p.
 article
100 Morphologic and prognostic significance of karyotype abnormalities in de novo myelodysplastic syndromes (MDS) 1991
 15 S p. 21-
1 p.
 article
101 Myelodysplastic syndrome associated with chronic lymphocytic leukaemia: A report of three cases Vallespí, T.
 1991
 15 S p. 20-
1 p.
 article
102 Myelodysplastic syndromes: Cytogenetic studies of 130 cases Donti, E.
 1991
 15 S p. 21-
1 p.
 article
103 Neutralization of leukocyte-derived inhibitory activity produced by MDS patients with monoclonal antibody against H-subunit-rich ferritin 1991
 15 S p. 30-
1 p.
 article
104 Phase I trial of amonafide (AM) for poor prognosis acute leukemias 1991
 15 S p. 32-
1 p.
 article
105 Prognostic assessment of the myelodysplastic syndromes (MDS). Validity of a simple scoring system for clinical usage 1991
 15 S p. 17-
1 p.
 article
106 Prognostic factors in MDS: A mathematical model Montillo, M.
 1991
 15 S p. 16-
1 p.
 article
107 Prognostic significance of bone marrow CFU-GM and cytogenetic studies in primary myelodisplastic syndromes (MDS) 1991
 15 S p. 28-
1 p.
 article
108 Prognostic value of chromosome analysis in myelodysplastic syndromes Torrabadella, M.
 1991
 15 S p. 21-
1 p.
 article
109 Promising results in MDS-AML after combination treatment with GM-CSF and chemotherapy Bernell, Per
 1991
 15 S p. 34-
1 p.
 article
110 5q deletion in MDS. Prognostic value of additional cytogenetic changes and “typical” dysmegakaryopoiesis (dysMK) 1991
 15 S p. 18-
1 p.
 article
111 Recombinant human erythropoietin for the treatment of anaemia in the myelodysplastic syndromes 1991
 15 S p. 33-
1 p.
 article
112 Recombinant human erythropoietin for the treatment of anaemia in the myelodysplastic syndromes 1991
 15 S p. 22-
1 p.
 article
113 Recombinant human erythropoietin (rh Epo): A possible treatment for the anemia of myelodysplastic syndromes (MDS) Ismard, F.
 1991
 15 S p. 32-
1 p.
 article
114 Refractory anaemia with ring sideroblasts (RAS): A simple scoring system based on easily available parameters Vallespí, T.
 1991
 15 S p. 18-
1 p.
 article
115 Refractory anaemia with ring sideroblasts (RAS): Caracterization and prognostic factors Vallespí, T.
 1991
 15 S p. 18-
1 p.
 article
116 Risk adapted therapeutic approaches for CMML 1991
 15 S p. 32-
1 p.
 article
117 Secondary myelodysplastic syndrome in lymphoproliferative diseases 1991
 15 S p. 20-
1 p.
 article
118 Serum biochemical parameters are greatly correlated to haematologic findings and may serve as indicators of the proliferative activity in chronic myelomonocytic leukaemia (CMML) 1991
 15 S p. 17-
1 p.
 article
119 Significance of butyrate-esterase examination for the classification of CMML subtypes 1991
 15 S p. 17-
1 p.
 article
120 Significance of the responses of patients with myelodysplastic syndromes (MDS) to various treatments 1991
 15 S p. 34-
1 p.
 article
121 Soluble IL-2 R levels in myelodysplastic syndromes 1991
 15 S p. 26-
1 p.
 article
122 Survival is related to the reduction of megakaryopoiesis in chronic myelomonocytic leukemia (CMML) Gardais, J.
 1991
 15 S p. 18-
1 p.
 article
123 Tests of rHuEPO administration in patients affected by mielodisplastic syndrome endocrino-metabolic evaluation Savioli, M.
 1991
 15 S p. 33-
1 p.
 article
124 The FGR protein kinase activity in neutrophils of patients with MDS and CML 1991
 15 S p. 29-
1 p.
 article
125 The reactivities of bone marrow cells with K167, bromodeoxyuridine and GM-CSF MoAbs in childhood MDS Mural Tunčcer, A.
 1991
 15 S p. 28-
1 p.
 article
126 The significance of TDT-positive subpopulations in MDS 1991
 15 S p. 31-
1 p.
 article
127 The use of immunophenotyping for prediction of early conversion to acute leukemia in myelodysplastic syndromes Mittelman, M.
 1991
 15 S p. 26-
1 p.
 article
128 Transformation in primary myelodysplastic syndromes: Clinical aspects and risk factors Mijović, A
 1991
 15 S p. 16-
1 p.
 article
129 Treatment of myelodysplastic syndromes (MDS) with recombinant human erythropoietin (rHuEPO): Preliminary clinical results Petti, M.C.
 1991
 15 S p. 33-
1 p.
 article
130 Treatment of myelodysplastic syndromes transformed (MDS-T) into AML with the combination of two intercalating agents: Mitoxantrone and daunorubicin plus oncovin (DON) 1991
 15 S p. 31-
1 p.
 article
131 Treatment of myelodysplastic syndromes with human granulocytic-macrophage colony-stimulating factor (GM-CSF) or GM-CSF combined with low dose (ARA-C) Economopoulos, T.
 1991
 15 S p. 34-
1 p.
 article
132 Trisomy 8 detection in granulomonocytic, erythrocytic and megakaryocytic lineages by CISS hybridization in a case of RARS complicating the course of PNH Parlier, V.
 1991
 15 S p. 22-
1 p.
 article
133 Unexplained macrocytosis in the elderly. A sign of myelodysplasia 1991
 15 S p. 19-
1 p.
 article
134 Variable patterns of lymphoid involvement in myelodysplastic syndromes (MDS) 1991
 15 S p. 25-
1 p.
 article
                             134 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands